Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
Nephrology Dialysis Transplantation
Journal
Overview
Identity
Overview
Publication Venue For
Identifying critically important vascular access outcomes for trials in haemodialysis: An international survey with patients, caregivers and health professionals
. 35:657-668.
2020
Serum albumin concentration and risk of end-stage renal disease: The REGARDS study
. 33:1770-1777.
2018
Association of serum albumin levels with kidney function decline and incident chronic kidney disease in elders
. 33:986-992.
2018
Renal replacement therapy intensity for acute kidney injury and recovery to dialysis independence: A systematic review and individual patient data meta-analysis
. 33:1017-1024.
2018
Noninvasive diagnosis of chronic kidney diseases using urinary proteome analysis
. 32:2079-2089.
2017
Vitamin D treatment attenuates cardiac FGF23/FGFR4 signaling and hypertrophy in uremic rats
. 32:1493-1503.
2017
The pressing need for real-time risk assessment of hospital-acquired acute kidney injury
. 32:766-770.
2017
Competing risks: you only die once
. 31:1033-1035.
2016
Connecting the dots on fibroblast growth factor 23 and left ventricular hypertrophy
. 31:1031-1033.
2016
Induction of cardiac FGF23/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease
. 31:1088-1099.
2016
Fibroblast growth factor 23 and heart failure: The plot thickens
. 31:688-690.
2016
APOL1 nephropathy risk variants are associated with altered high-density lipoprotein profiles in African Americans
. 31:602-608.
2016
N-Acetylgalactosaminide α2,6-sialyltransferase II is a candidate enzyme for sialylation of galactose-deficient IgA1, the key autoantigen in IgA nephropathy
. 30:234-238.
2015
Treatment of established left ventricular hypertrophy with fibroblast growth factor receptor blockade in an animal model of CKD
. 29:2028-2035.
2014
The effect of everolimus on renal angiomyolipoma in patients with tuberous sclerosis complex being treated for subependymal giant cell astrocytoma: Subgroup results from the randomized, placebo-controlled, Phase 3 trial EXIST-1
. 29:1203-1210.
2014
Comparison of absolute serum creatinine changes versus Kidney Disease: Improving Global Outcomes consensus definitions for characterizing stages of acute kidney injury
. 28:1447-1454.
2013
Experimental evidence of cell dissemination playing a role in pathogenesis of IgA nephropathy in multiple lymphoid organs
. 28:320-326.
2013
Expression of fgf23 and αklotho in developing embryonic tissues and adult kidney of the zebrafish, Danio rerio
. 27:4314-4322.
2012
Chronic renal denervation increases renal tubular response to P2X receptor agonists in rats: Implication for renal sympathetic nerve ablation
. 27:3443-3448.
2012
Prevalence and prognosis of unrecognized myocardial infarctions in chronic kidney disease
. 27:3482-3488.
2012
Solute clearance in CRRT: Prescribed dose versus actual delivered dose
. 27:952-956.
2012
Renal outcomes of agalsidase beta treatment for Fabry disease: role of proteinuria and timing of treatment initiation.
. 27:1042-1049.
2012
Incidence of stroke symptoms among adults with chronic kidney disease: Results from the REasons for Geographic and Racial Differences in Stroke (REGARDS) study
. 27:166-173.
2012
Primary hyperoxaluria Type 1: indications for screening and guidance for diagnosis and treatment.
. 27:1729-1736.
2012
Renal outcomes of agalsidase beta treatment for Fabry disease: Role of proteinuria and timing of treatment initiation
. 27:1042-1049.
2012
Variability in urinary oxalate measurements between six international laboratories
. 26:3954-3959.
2011
IgA1 immune complexes from pediatric patients with IgA nephropathy activate cultured human mesangial cells
. 26:3451-3457.
2011
Role of lean body mass in estimating glomerular filtration rate in Alzheimer disease
. 26:2222-2231.
2011
Severe venous neointimal hyperplasia prior to dialysis access surgery
. 26:2264-2270.
2011
Diuretics, calciuria and secondary hyperparathyroidism in the Chronic Renal Insufficiency Cohort
. 26:1258-1265.
2011
Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney disease
. 26:584-591.
2011
Race differences in prevalence of chronic kidney disease among young adults using creatinine-based glomerular filtration rate-estimating equations
. 25:3934-3939.
2010
Racial differences in postprandial mineral ion handling in health and in chronic kidney disease
. 25:3970-3977.
2010
A case of infection-associated antiproteinase-3-negative cytoplasmic antineutrophil cytoplasmic antibody pauci-immune focal necrotizing glomerulonephritis
. 25:3119-3123.
2010
Glomerulonephritis after hematopoietic cell transplantation: IgA nephropathy with increased excretion of galactose-deficient IgA1
. 25:1708-1713.
2010
End-stage renal disease in patients with Fabry disease: Natural history data from the Fabry Registry
. 25:769-775.
2010
Tissue distribution and biological activities of immune complexes are determined by their size and composition
. 25:1007.
2010
Acute kidney injury: Where's the consensus about its definition
. 25:9-11.
2010
Scoring system for renal pathology in Fabry disease: Report of the International Study Group of Fabry Nephropathy (ISGFN)
. 25:2168-2177.
2010
Who should be referred for a fistula? A survey of nephrologists
. 25:2644-2651.
2010
Exploration of anaemia as a progression factor in African Americans with cardiovascular disease
. 24:3404-3411.
2009
A comparison of observed versus estimated baseline creatinine for determination of RIFLE class in patients with acute kidney injury
. 24:2739-2744.
2009
Fabry disease: Progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy
. 24:2102-2111.
2009
Nephropathy in Fabry disease: The importance of early diagnosis and testing in high-risk populations
. 24:1736-1743.
2009
Association of chronic kidney disease with outcomes in chronic heart failure: A propensity-matched study
. 24:186-193.
2009
IgA Nephropathy in children and adults: Comparison of histologic features and clinical outcomes
. 23:2537-2545.
2008
Nephropathy in males and females with Fabry disease: Cross-sectional description of patients before treatment with enzyme replacement therapy
. 23:1600-1607.
2008
Effect of risedronate on high-dose corticosteroid-induced bone loss in patients with glomerular disease
. 22:1593-1600.
2007
Haem oxygenase-1 - A culprit in vascular and renal damage?
. 22:1495-1499.
2007
Genome scan of glomerular filtration rate and albuminuria: The HyperGEN study
. 22:763-771.
2007
Arteriovenous access outcomes in haemodialysis patients with HIV infection
. 22:465-470.
2007
Catheter-related bacteraemia in haemodialysis patients with HIV infection
. 21:3185-3188.
2006
IgA-containing immune complexes in the urine of IgA nephropathy patients
. 21:2478-2484.
2006
Glyoxylate reductase activity in blood mononuclear cells and the diagnosis of primary hyperoxaluria type 2
. 21:2292-2295.
2006
Mizoribine reduces renal injury and macrophage infiltration in non-insulin-dependent diabetic rats
. 20:1573-1581.
2005
Racial disparities in the association of foetal growth retardation to childhood blood pressure
. 20:1592-1597.
2005
Recurrent IgA nephropathy after renal transplantation despite immunosuppressive regimens with mycophenolate mofetil
. 20:1214-1221.
2005
The spectrum of infection-related morbidity in hospitalized haemodialysis patients
. 20:1180-1186.
2005
AL-amyloidosis is underdiagnosed in renal biopsies
. 19:3050-3053.
2004
Association of pelvic arterial calcification with arteriovenous thigh graft failure in haemodialysis patients
. 19:2564-2569.
2004
Sodium ferric gluconate complex in haemodialysis patients: A prospective evaluation of long-term safety
. 19:1576-1580.
2004
Treatment of catheter-related bacteraemia with an antibiotic lock protocol: Effect of bacterial pathogen
. 19:1237-1244.
2004
Galectin-3-positive cell infiltration in human diabetic nephropathy
. 19:602-607.
2004
WNK kinases, distal tubular ion handling and hypertension
. 18:2463-2467.
2003
Novel concepts in understanding and management of glomerular proteinuria
. 17:951-955.
2002
Protease inhibitor therapy for HIV infection: The effect on HIV-associated nephrotic syndrome
. 14:744-747.
1999
Crossover comparison of intravenous and subcutaneous recombinant human erythropoietin in a small haemodialysis unit [6]
. 13:2979-2980.
1998
Immunological studies of IgA nephropathy in blacks reveal elevations of serum IgA2 as well as IgA1
. 9:1324-1329.
1994
Genetic factors in primary IgA nephropathy
. 2:134-142.
1987
Identity
International Standard Serial Number (issn)
0931-0509
Electronic International Standard Serial Number (eissn)
1460-2385